Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2011 by University of Vermont.
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
American Cancer Society, Inc.
Information provided by:
University of Vermont
ClinicalTrials.gov Identifier:
NCT01341171
First received: July 7, 2010
Last updated: April 21, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2012
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)